Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
San Juan Oncology Associates, Farmington, New Mexico, United States
Pacific Cancer Medical Center, Anaheim, California, United States
Washington University School of Medicine Center for Advanced Medicine, Saint Louis, Missouri, United States
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Inova Schar Cancer Institute, Fairfax, Virginia, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.